Lung Transplant Techniques for Lung Transplant
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine which lung transplant technique better prevents primary graft dysfunction, a complication where the new lung doesn't function well immediately. It compares two methods: one performed "off-pump" (without a machine to support circulation) and another using venoarterial ECMO (a machine that assists in pumping and oxygenating blood). Individuals needing a double lung transplant with specific lung pressure may qualify to participate, provided they do not require certain pre-surgery support or have undergone specific previous lung surgeries. As an unphased trial, this study allows participants to contribute to pioneering research that could enhance lung transplant outcomes.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that these lung transplant techniques are safe?
A previous study demonstrated that off-pump lung transplantation is a safe option. This method avoids cutting through the breastbone, reducing complications and pain after surgery while maintaining better chest function.
Research on venoarterial ECMO, a machine that supports heart and lung function during surgery, has shown it is also safe. It can result in fewer lung and kidney problems compared to other support methods. Both treatments have been studied for their safety and have shown promising results.
Overall, studies have found both methods to be well-tolerated. The choice between them often depends on the specific needs of the patient and the medical team’s expertise.12345Why are researchers excited about this trial?
Researchers are excited about these lung transplantation techniques because they offer innovative approaches that could improve outcomes for patients needing lung transplants. Off-pump lung transplantation eliminates the need for cardiopulmonary bypass, potentially reducing complications associated with traditional methods. On the other hand, the Venoarterial ECMO technique provides circulatory support during the transplant, which can stabilize patients with severe heart-lung conditions. Both techniques aim to enhance the safety and effectiveness of lung transplants, which are crucial for patients with end-stage lung disease.
What evidence suggests that these lung transplant techniques are effective for reducing primary graft dysfunction?
Research has shown that off-pump lung transplantation, a technique under study in this trial, can be effective and safe. This method avoids large chest incisions, potentially reducing pain and post-surgery complications. Studies also suggest it could improve chest mobility.
Another technique in this trial is venoarterial ECMO, a machine used during lung transplants to support the heart and lungs. It maintains blood and oxygen flow, which might shorten hospital stays and improve survival rates. Both methods have shown promising results, but their effectiveness can depend on individual circumstances.12345Who Is on the Research Team?
Mauricio Villavicencio, MD, MBA
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for people who need both lungs replaced and can have surgery with or without a heart-lung machine (ECMO), as decided by their surgeon. They must have a certain level of blood pressure in the lungs to qualify. It's not for those needing only one lung, multiple organs, re-transplants, or who had major lung surgeries before.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo bilateral lung transplantation using either off-pump or VA ECMO techniques
Follow-up
Participants are monitored for safety and effectiveness, including incidence of PGD, mortality, and other complications
Long-term follow-up
Participants are monitored for long-term outcomes such as transplant rejection and overall survival
What Are the Treatments Tested in This Trial?
Interventions
- Off-pump lung transplantation
- Venoarterial ECMO lung transplantation
Off-pump lung transplantation is already approved in European Union, United States, Canada for the following indications:
- End-stage lung disease
- Cystic fibrosis
- Bronchiectasis
- Pulmonary hypertension
- Emphysema
- Pulmonary fibrosis
- End-stage lung disease
- Cystic fibrosis
- Bronchiectasis
- Pulmonary hypertension
- Emphysema
- Pulmonary fibrosis
- End-stage lung disease
- Cystic fibrosis
- Bronchiectasis
- Pulmonary hypertension
- Emphysema
- Pulmonary fibrosis
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor